Wegovy improves glycaemic control, which is beneficial, but SSRIs including sertraline have been associated with both hypoglycaemia and hyperglycaemia in different patients
Bristol Myers Squibb Headquarters: New York, New York, USA Number of employees: 19,437 Year founded: 1887 Revenue (2025): $48.2 billion Forbes overall rank: 523 Bristol Myers Squibb (BMS) earned roughly $48.2 billion in 2025, with growth driven by products such as PD-1 inhibitor Opdivo (nivolumab), CTLA-4 inhibitor Yervoy (ipilimumab), anemia drug Reblozyl (luspatercept-aamt) and Camzyos (mavacamten) for obstructive hypertrophic cardiomyopathy (oHCM), though overall sales have been pressured by patent expirations and pricing reforms
They also reported less overall tiredness
The monitoring priorities it lists are renal function, dehydration risk, and nutritional status
Medical Disclaimer: Mounjaro 5mg KwikPen is a prescription-only medicine and must be used strictly under the supervision and guidance of a qualified healthcare professional
Johnson, M., et al